FDA warns sanitizer firms on MRSA claims; Roche sues Sandoz over generic Valcyte;

@FiercePharma: J&J defends executive pay to institutional investors. News | Follow @FiercePharma

> The FDA issued four warning letters to companies that market over-the-counter drug products, including hand sanitizers, that claim to prevent infection from methicillin-resistant Staphylococcus aureus bacteria (MRSA). FDA release

> Roche's Genentech unit has sued Sandoz for planning to sell a generic version of Valcyte, which treats a virus that afflicts transplant patients and people with AIDS, before Genentech's patent expires. News

> Watson Pharmaceuticals is challenging Daiichi Sankyo's patent on the cholesterol drug Welchol to clear the way for a sale of a generic version. Story

> The Obama administration urged a federal judge to dismiss a lawsuit that challenged a decision to allow unapproved drugs to be imported for use in executions of death row inmates. Item

> Eisai's sea sponge-derived breast cancer drug Halaven has been launched in the UK following approval from European regulators a month ago. Article

> The new owner of Genzyme's former genetics testing business plans to eliminate 169 jobs at its Westborough site this year and next, according to a memo circulated last week. Report

> Mylan has started selling a generic version of the Novartis antiviral drug Famvir. News

> Covidien reported a higher-than-expected quarterly profit, helped by strong demand for its medical devices, while pharma sells fell by four percent to $490 million. Item

Biotech News

 @FierceBiotech: Sangart raises $50M to fund critical Ph2b ischemia study. Report | Follow @FierceBiotech

 @JohnCFierce: Janssen dumps antibiotic pact as it shifts out of the field, focuses on vaccines. Report | Follow @JohnCFierce

> Dissidents say Actelion battle will hinge on institutional investors. Story

> Valeant offers a stick, a carrot and a May 12 deadline to Cephalon investors. Article 

> VC report: Rounds get fatter as the number of deals shrinks. News 

Vaccines News

> NanoBio pursues nasal vaccine to prevent UTIs. Report 

> Report: GlaxoSmithKline in talks to buy India vaccine unit. Item 

> Novavax gets a new CEO. News 

> Inovio, Transgene and ChronTech enter HepC pact. Article 

> Aduro licenses BioSante cancer vaccines. Story 

Manufacturing News

> Hamburg pushes science, enforcement in FDA strategy. News 

> J&J quantifies manufacturing woes in financials. Article  

> Pfizer plant prepped before demolition to contain killer API. Item 

> FDA director offers QbD insight. Story 

> Reddy: Process expertise, luck drove success. News 

> U.S. plants fall to GSK strategy shift. Article 

And Finally... Small doses of aspirin can lower the risk of heart attacks in people who never had heart disease, but the blood-thinning drug doesn't appear to cut the chances of strokes or dying from the disease. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.